Previous Article | Next Article ![]()
Journal of Clinical Microbiology, June 2001, p. 2079-2082, Vol. 39, No. 6
Geisinger Medical Center, Danville,
Pennsylvania
Received 12 January 2001/Returned for modification 22 February
2001/Accepted 27 March 2001
BacT/Alert FAN blood culture bottles have been shown to enhance the
recovery of bacteria and yeast from blood compared with standard
BacT/Alert bottles. It is well established that standard BacT/Alert
blood culture bottles require no more than 5 days of incubation for the
detection of routine bacteria and yeast. It is less clear, however,
whether FAN bottles also routinely require 5 days of incubation. To
address this question, we recently reviewed the results of 17,887 blood
culture sets collected in FAN blood culture bottles at Geisinger
Medical Center. Of these cultures, 1,780 were positive for bacteria or
yeast, yielding a total of 1,242 clinically significant isolates. The
numbers of isolates recovered on days 1, 2, 3, 4, and 5 were as
follows: (values in parentheses are percentages of total significant
isolates): 877 (71%), 269 (22%), 65 (5%), 18 (1%) and, 13 (1%),
respectively. In total, 97.5% of all clinically significant isolates
were detected in the first 3 days of incubation. Of the 31 significant
isolates detected on day 4 or 5 of incubation, 17 were detected in
concurrent blood cultures within the first 3 days of incubation. Chart
reviews were conducted for the 13 patients with the remaining 14 isolates detected on day 4 or 5 to determine whether therapy was
changed due to this blood culture result. Therapy was changed for only 1 patient. These results suggest that it may not be necessary to
routinely incubate FAN blood culture bottles for more than 3 days.
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.6.2079-2082.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Three Days of Incubation May Be Sufficient for
Routine Blood Cultures with BacT/Alert FAN Blood Culture
Bottles
*
Corresponding author. Mailing address: Division of
Laboratory Medicine, Geisinger Medical Center, Danville, PA 17822-0131. Phone: (570) 271-7467. Fax: (570) 271-6105. E-mail:
pbourbeau{at}geisinger.edu.
Present address: FDA Center for Drug Evaluation and Research,
Rockville, MD 20857.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»